Search Page

1

Cite

Share

Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).

Christodoulou C, Kalofonos HP, Briasoulis E, Bafaloukos D, Makatsoris T, Koutras A, Skarlos DV, Samantas E. Christodoulou C, et al. Among authors: koutras a. Cancer Chemother Pharmacol. 2006 Jan;57(2):207-12. doi: 10.1007/s00280-005-0034-3. Epub 2005 Jul 19. Cancer Chemother Pharmacol. 2006. PMID: 16028103 Clinical Trial.

Cite

Share

2

Cite

Share

Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial.

Iconomou G, Koutras A, Rigopoulos A, Vagenakis AG, Kalofonos HP. Iconomou G, et al. Among authors: koutras a. J Pain Symptom Manage. 2003 Jun;25(6):512-8. doi: 10.1016/s0885-3924(03)00070-8. J Pain Symptom Manage. 2003. PMID: 12782431 Clinical Trial.

Cite

Share

3

Cite

Share

Surgical management of cerebral metastases from non-small cell lung cancer.

Koutras AK, Marangos M, Kourelis T, Partheni M, Dougenis D, Iconomou G, Vagenakis AG, Kalofonos HP. Koutras AK, et al. Tumori. 2003 May-Jun;89(3):292-7. Tumori. 2003. PMID: 12908786

Cite

Share

4

Cite

Share

Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy.

Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP. Iconomou G, et al. Among authors: koutras a. Cancer. 2004 Jul 15;101(2):404-11. doi: 10.1002/cncr.20385. Cancer. 2004. PMID: 15241840

Cite

Share

5

Cite

Share

Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?

Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Iconomou A, Kalofonos HP, Chroni E. Argyriou AA, et al. Among authors: koutras a. Support Care Cancer. 2005 Aug;13(8):647-51. doi: 10.1007/s00520-005-0776-9. Epub 2005 Feb 15. Support Care Cancer. 2005. PMID: 15711945

Cite

Share

6

Cite

Share

Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?

Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E. Argyriou AA, et al. Among authors: koutras a. Support Care Cancer. 2006 Mar;14(3):223-9. doi: 10.1007/s00520-005-0868-6. Epub 2005 Jul 15. Support Care Cancer. 2006. PMID: 16021477

Cite

Share

7

Cite

Share

A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.

Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP. Argyriou AA, et al. Among authors: koutras a. Support Care Cancer. 2006 Nov;14(11):1134-40. doi: 10.1007/s00520-006-0072-3. Epub 2006 Apr 19. Support Care Cancer. 2006. PMID: 16622646 Clinical Trial.

Cite

Share

8

Cite

Share

A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.

Kosmas C, Tsavaris N, Syrigos K, Koutras A, Tsakonas G, Makatsoris T, Mylonakis N, Karabelis A, Stathopoulos GP, Kalofonos HP. Kosmas C, et al. Among authors: koutras a. Cancer Chemother Pharmacol. 2007 Jan;59(1):51-9. doi: 10.1007/s00280-006-0242-5. Epub 2006 Apr 19. Cancer Chemother Pharmacol. 2007. PMID: 16622691 Clinical Trial.

Cite

Share

9

Cite

Share

Capecitabine-induced hypertriglyceridemia: a report of two cases.

Koutras AK, Habeos IG, Vagenakis AG, Kalofonos HP. Koutras AK, et al. Anticancer Res. 2006 May-Jun;26(3B):2249-51. Anticancer Res. 2006. PMID: 16821596

Cite

Share

10

Cite

Share

Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.

Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP. Argyriou AA, et al. Among authors: koutras a. J Pain Symptom Manage. 2006 Sep;32(3):237-44. doi: 10.1016/j.jpainsymman.2006.03.013. J Pain Symptom Manage. 2006. PMID: 16939848 Clinical Trial.

Cite

Share